The Food and Drug Administration on Monday approved Schering-Plough's prefilled pen-like syringe that contains the company's PEG-Intron hepatitis C treatment. The device, called the PEG-Intron Redipen, was designed to be easier to use than traditional syringes and vials of the medication. It is expected to be available in the United States in early 2004. PEG-Intron Redipen is already sold in Europe. Hepatitis C is a common coinfection among HIV-positive people and is one of the leading killers of people who are infected with HIV. Hepatitis C is commonly transmitted through contact with infected blood, but studies have shown it may also be transmitted through sexual contact.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved














